Fraudulent versions of Allergan Inc brand Botox have been sold in the US, according to the Food and Drug administration; the FDA posted an alert on their website detailing the product and letting patients know that the outer carton is counterfeit, whilst the vial inside is foreign and not approved for sale in the United States.
The agency said ‘FDA cannot confirm that the manufacture, quality, and handling of these products follow U.S. standards.’ Allergan added that the illegally imported Botox could be of low quality and may put patient’s health at risk, as well as violating federal laws – authentic products are stored and transported by Allergan to strict specifications.
The FDA added that the fake Botox was being sold under the names ‘Onlinebotox.com’ ‘Online Botox Pharmacy’ and ‘Onlinebotox’ and was actually being solicited by fax, rather than online – by offering prices below those of products approved by the FDA. As recently as last December, the FDA alerted over 350 medical practices to unapproved medication that came from a foreign supplier; now governing bodies in the US are looking to create a national set of standards for tracking prescription drugs through the distribution chain, in order to stop counterfeit or contaminated products from getting through to the public. They suggested new laws that would trace drugs either in lots or as individual packages.